Want to join the conversation?
$REGN 2Q15 Call: Phase 2 study of Dupilumab in eosinophilic esophagitis is ongoing and currently enrolling patients. NURSERY-PreTerm is enrolling patients in the Southern Hemisphere where the RSV season is from May through October; a second Phase 3 trial in this indication is planned for later this year in Northern Hemisphere.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.